Abstract
51. A First-In-Human Phase I Study of LYT-300, a First-In-Class Orally Bioavailable Prodrug of the Neurosteroid Allopregnanolone That is Absorbed via the Lymphatic System
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have